Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Taro Pharmaceutical Industries Ltd. | Haifa Bay, Israel | Makes it and makes the active ingredient | No problems foundDec 8, 2022 · 7 inspections |
Recalls
- Aug 3, 2026 · Class II · Sun Pharmaceutical Industries Inc
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Lots: Lot # AD94033, Exp Date: 5/31/2028. - Oct 21, 2014 · Class III · Taro Pharmaceuticals U.S.A., Inc.
Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval.
Lots: Lot 137393, exp. 10/2016
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Carbamazepine: every company that makes it
- Form
- tablet, oral
- Strength
- 200 mg
- Approval
- ANDA ANDA074649
- On the market since
- Oct 3, 1996
- Package NDCs
51672-4005-151672-4005-251672-4005-3- Official label
- DailyMed (National Library of Medicine), updated Aug 30, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?